---  
layout: startup_page  
title: "LoQus23 Therapeutics"  
id: "loqus23.com"  
permalink: "/loqus23therapeuticsloqus23.com02182025/"  
website: "https://loqus23.com/"  
funding_round: "Series A"  
funding_amount: "£35M"  
investors: "Forbion, SV Health Investors' Dementia Discovery Fund, Novartis Venture Fund"  
about: "LoQus23 Therapeutics is a biotechnology company developing small molecule drugs to treat Huntington's Disease and other triplet repeat expansion diseases. Their approach aims to stop DNA instability and slow neurodegeneration. Their lead program, a potent allosteric small molecule MSH3 inhibitor, is expected to enter the clinic in 2026."  
markets: "Biotech"  
hq: "Cambridge, England, United Kingdom"  
founded_year: "2019"  
linkedin: "https://uk.linkedin.com/company/loqus23-therapeutics-ltd"  
twitter: "https://twitter.com/loqus23"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/loqus23-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/277398-91"  

date_display: "18-Feb-2025"  
date: "2025-02-18"

# SEO Optimization  
meta_title: "LoQus23 Therapeutics - Series A Funding (£35M)"  
meta_description: "LoQus23 Therapeutics, LoQus23 Therapeutics is a biotechnology company developing small molecule drugs to treat Huntington's Disease and other triplet repeat expansion disea..."  
meta_keywords: "LoQus23 Therapeutics, Biotech, Series A funding"  
canonical_url: "https://startup.projectstartups.com/loqus23therapeuticsloqus23.com02182025/"  
---